Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11284075 | chr2:242532988 | TA/T | 5.98E-11 | 176 | 25.77 | 25 | 10.3 | KM Plot |
PCPG | rs112842768 | chr13:114745781 | A/G | 0.000149 | 170 | 25.77 | 25.17 | 3.17 | KM Plot |
PCPG | rs11287506 | chr21:34613935 | AT/A | 0.000389 | 171 | 20.37 | 31.72 | 25.08 | KM Plot |
PCPG | rs112877133 | chr17:1410882 | T/G | 1.46E-5 | 174 | 25.05 | 25 | 25.17 | KM Plot |
PCPG | rs112882504 | chr17:1420825 | T/C | 1.64E-5 | 173 | 25.47 | 25.43 | 1.2 | KM Plot |
PCPG | rs112931321 | chr12:56667894 | C/T | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs112938594 | chr7:36168362 | A/C | 0.000446 | 177 | 25.87 | 24.5 | 14.37 | KM Plot |
PCPG | rs112939656 | chr17:1427085 | G/C | 1.25E-5 | 176 | 24.7 | 26.73 | 25.17 | KM Plot |
PCPG | rs112946952 | chr17:80493917 | AT/A | 4.82E-5 | 176 | 25.87 | 22.33 | 7.2 | KM Plot |
PCPG | rs112951389 | chr11:18147125 | T/TAAGG | 3.94E-5 | 175 | 26.43 | 24.1 | 6.7 | KM Plot |
PCPG | rs112959931 | chr16:90142852 | C/A | 8.58E-9 | 176 | 25.77 | 20.28 | 6.62 | KM Plot |
PCPG | rs112986141 | chr3:182611323 | G/A | 3.94E-6 | 173 | 25.87 | 26.57 | 13.27 | KM Plot |
PCPG | rs11303510 | chr2:136399543 | AT/A | 0.000219 | 177 | 25.7 | 25.67 | 14.5 | KM Plot |
PCPG | rs113040491 | chr12:131386545 | C/T | 1.62E-7 | 173 | 24.23 | 32.03 | 19.87 | KM Plot |
PCPG | rs113051356 | chr13:114179990 | G/A | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |